Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cyclooxygenase 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00367315
What this trial is testing

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)

Who this might be right for
Knee Osteoarthritis
Novartis 1,684
Early research (Phase 1)Study completedNCT00328432
What this trial is testing

Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy

Who this might be right for
Breast Cancer
University of Kansas 100
Testing effectiveness (Phase 2)Study completedNCT00314262
What this trial is testing

Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor

Who this might be right for
Precancerous Conditions
Emory University 17
Not applicableUnknownNCT02790203
What this trial is testing

Perioperative Use of a Selective COX2 Inhibitor in Patients Undergoing Elective Colorectal Surgery: the Effect on Post-operative Bowel Motility and Post-operative Pain

Who this might be right for
Prevention of Post Operative Ileus
Sheba Medical Center 100
Very early researchStudy completedNCT02062255
What this trial is testing

Impact of COX2 on Sera Biomarkers From Obese Subjects

Who this might be right for
Breast Cancer Survivors
The University of Texas Health Science Center at San Antonio 126
Large-scale testing (Phase 3)Study completedNCT00385606
What this trial is testing

Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC

Who this might be right for
Advanced Non-small Cell Lung Cancer
National Cancer Institute, Naples 400
Testing effectiveness (Phase 2)Study completedNCT01269515
What this trial is testing

Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients

Who this might be right for
HIV
Dag Kvale 60
Testing effectiveness (Phase 2)Study completedNCT00099047
What this trial is testing

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaSmoldering Multiple Myeloma
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Ended earlyNCT02840162
What this trial is testing

Pre-Prostatectomy Celecoxib or Placebo

Who this might be right for
Adenocarcinoma of the ProstateProstate Cancer
OHSU Knight Cancer Institute 34
Not applicableLooking for participantsNCT06535568
What this trial is testing

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Who this might be right for
Coronary DiseaseHeart DiseasesCardiovascular Diseases+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS 576
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634094
What this trial is testing

Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer

Who this might be right for
Ovarian Cancer
Kalinski, Pawel, MD, PhD 28
Large-scale testing (Phase 3)UnknownNCT02438709
What this trial is testing

Effect Observation Study of COX-2 Inhibitor to Treat Primary Hypertrophic Osteoarthropathy

Who this might be right for
Primary Hypertrophic Osteoarthropathy
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00581971
What this trial is testing

Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer

Who this might be right for
Cancer
University of Alabama at Birmingham 30
Testing effectiveness (Phase 2)Ended earlyNCT00073970
What this trial is testing

Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT00231829
What this trial is testing

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

Who this might be right for
Uterine Cancer
Mark H. Einstein 23
Post-approval studies (Phase 4)Study completedNCT03704623
What this trial is testing

Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic

Who this might be right for
Acute Renal ColicUreteric Stone
Mansoura University 200
Testing effectiveness (Phase 2)Study completedNCT00006299
What this trial is testing

Celebrex for Pain Relief After Oral Surgery

Who this might be right for
Facial Pain
National Institute of Dental and Craniofacial Research (NIDCR) 120
Testing effectiveness (Phase 2)Looking for participantsNCT06839144
What this trial is testing

Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression

Who this might be right for
Ovarian CancerOvarian Cancer Metastatic Recurrent
Tel-Aviv Sourasky Medical Center 60
Post-approval studies (Phase 4)Study completedNCT01479829
What this trial is testing

Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression

Who this might be right for
Bipolar Depression
Loyola University 100
Post-approval studies (Phase 4)Study completedNCT05615948
What this trial is testing

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Who this might be right for
Treatment Resistant DepressionMajor Depressive DisorderAnalgesia+10 more
Theresa Jacob, PhD, MPH 15
Next Page